Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Blood as a Submucosal Cushion During Endoscopic Polypectomy and Mucosal Resection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00583466
Recruitment Status : Completed
First Posted : December 31, 2007
Results First Posted : September 13, 2017
Last Update Posted : September 13, 2017
Sponsor:
Information provided by (Responsible Party):
Johns Hopkins University

Brief Summary:
For removal of large flat lesions of the gastro-intestinal tract injection of a solution under the lesion creates a "safety" cushion and protects from damage to the gastrointestinal tract wall. Various solutions are currently used, but some of them are easy to inject but quickly dissipate (normal saline),other solutions are more longer lasting (hydroxypropyl methylcellulose, hyaluronic acid, etc) but are very difficult to inject and can be expensive and not always available. The investigators performed previously animal experiments which demonstrated that blood is easy to inject and creates a protective cushion which lasts longer than other fluids which are currently used for protective cushion creation.

Condition or disease Intervention/treatment Phase
Large Polyps in the Gastrointestinal Tract Drug: Autologous blood injection Drug: Normal saline Drug: HPMC Phase 2

Detailed Description:
For removal of large flat lesions of the gastro-intestinal tract injection of a solution under the lesion creates a "safety" cushion and protects from damage to the gastrointestinal tract wall. Various solutions are currently used, but some of them are easy to inject but quickly dissipate (normal saline),other solutions are more longer lasting (hydroxypropyl methylcellulose, hyaluronic acid, etc) but are very difficult to inject and can be expensive and not always available. The investigators decided to use blood drawn from the patient for injection under the lesion. The investigators performed previously animal experiments which demonstrated that blood is easy to inject and creates a protective cushion which lasts longer than other fluids which are currently used for protective cushion creation. Blood can also have local hemostatic action preventing from bleeding during polypectomy.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 18 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Evaluation of Blood as a Submucosal Cushion During Endoscopic Polypectomy and Mucosal Resection
Actual Study Start Date : May 2007
Actual Primary Completion Date : May 2008
Actual Study Completion Date : May 2008

Arm Intervention/treatment
Active Comparator: 1 Normal saline arm
Polypectomy with normal saline injected for submucosal cushion creation
Drug: Normal saline
Normal saline will be injected under the lesion to create submucosal cushion

Active Comparator: 2 HPMC arm
Polypectomy after injection of hydroxypropyl methylcellulose (HPMC) to create submucosal cushion
Drug: HPMC
Hydroxypropyl methylcellulose (HPMC) will be injected under the lesion to create submucosal cushion

Experimental: 3 Blood arm
Polypectomy after injection of autologous blood
Drug: Autologous blood injection
Autologous blood will be drawn from the patient and then reinjected under the lesion to create a safety cushion




Primary Outcome Measures :
  1. Duration of the Submucosal Cushion [ Time Frame: Immediately after the procedure, Up to 5 minutes ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Polyps equal or larger than 1 cm

Exclusion Criteria:

  • Coagulopathy
  • Inability to sign informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00583466


Locations
Layout table for location information
United States, Maryland
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21205
Sponsors and Collaborators
Johns Hopkins University
Investigators
Layout table for investigator information
Principal Investigator: Sergey V. Kantsevoy, M.D., Ph.D. Johns Hopkins University
Publications:
Layout table for additonal information
Responsible Party: Johns Hopkins University
ClinicalTrials.gov Identifier: NCT00583466    
Other Study ID Numbers: NA_00008376
First Posted: December 31, 2007    Key Record Dates
Results First Posted: September 13, 2017
Last Update Posted: September 13, 2017
Last Verified: September 2017
Keywords provided by Johns Hopkins University:
submucosal cushion
polypectomy
endoscopic mucosal resection